Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AMPE NASDAQ:ONCSQ NASDAQ:PXMD NASDAQ:SMFL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMPEAmpio Pharmaceuticals$0.00$0.00$0.00▼$0.13$3K5.09687 shs3 shsONCSQOncoSec Medical$0.00$0.00▼$0.00$1K-19.7204 shsN/APXMDPaxMedica$0.00-50.0%$0.00$0.00▼$0.00$1K-0.99648 shs1,297 shsSMFLSmart for Life$0.00-72.7%$0.01$0.00▼$1.28$2K17.065,858 shs508 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMPEAmpio Pharmaceuticals0.00%0.00%-6.90%-97.67%+22.73%ONCSQOncoSec Medical0.00%0.00%0.00%0.00%0.00%PXMDPaxMedica0.00%-50.00%-50.00%0.00%-99.88%SMFLSmart for Life0.00%-91.18%-95.16%-97.74%-99.96%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMPEAmpio Pharmaceuticals$0.00$0.00$0.00▼$0.13$3K5.09687 shs3 shsONCSQOncoSec Medical$0.00$0.00▼$0.00$1K-19.7204 shsN/APXMDPaxMedica$0.00-50.0%$0.00$0.00▼$0.00$1K-0.99648 shs1,297 shsSMFLSmart for Life$0.00-72.7%$0.01$0.00▼$1.28$2K17.065,858 shs508 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMPEAmpio Pharmaceuticals0.00%0.00%-6.90%-97.67%+22.73%ONCSQOncoSec Medical0.00%0.00%0.00%0.00%0.00%PXMDPaxMedica0.00%-50.00%-50.00%0.00%-99.88%SMFLSmart for Life0.00%-91.18%-95.16%-97.74%-99.96%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMPEAmpio Pharmaceuticals 0.00N/AN/AN/AONCSQOncoSec Medical 0.00N/AN/AN/APXMDPaxMedica 0.00N/AN/AN/ASMFLSmart for Life 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMPEAmpio PharmaceuticalsN/AN/AN/AN/A$4.04 per shareN/AONCSQOncoSec MedicalN/AN/AN/AN/AN/AN/APXMDPaxMedicaN/AN/AN/AN/A$0.46 per shareN/ASMFLSmart for Life$11.11M0.00N/AN/A($17.10) per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMPEAmpio Pharmaceuticals-$8.63M-$11.01N/A∞N/AN/AN/AN/AN/AONCSQOncoSec Medical-$34.18MN/A0.00N/AN/AN/AN/AN/AN/APXMDPaxMedica-$18.29MN/A0.00∞N/AN/A-3,167.89%-560.35%N/ASMFLSmart for Life-$22.68MN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMPEAmpio PharmaceuticalsN/AN/AN/AN/AN/AONCSQOncoSec MedicalN/AN/AN/AN/AN/APXMDPaxMedicaN/AN/AN/AN/AN/ASMFLSmart for LifeN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMPEAmpio PharmaceuticalsN/AN/AN/AONCSQOncoSec MedicalN/AN/AN/APXMDPaxMedicaN/A0.380.38SMFLSmart for LifeN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMPEAmpio Pharmaceuticals5.73%ONCSQOncoSec MedicalN/APXMDPaxMedica4.90%SMFLSmart for Life28.39%Insider OwnershipCompanyInsider OwnershipAMPEAmpio Pharmaceuticals3.30%ONCSQOncoSec Medical1.32%PXMDPaxMedica1.00%SMFLSmart for Life31.71%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMPEAmpio Pharmaceuticals201.14 million1.10 millionNo DataONCSQOncoSec Medical405.96 million5.88 millionNot OptionablePXMDPaxMedica211.31 million11.20 millionNot OptionableSMFLSmart for Life1107.09 million4.84 millionNot OptionableONCSQ, SMFL, AMPE, and PXMD HeadlinesRecent News About These CompaniesSmart for Life Inc. (SMFL) Analyst ResearchMarch 21, 2025 | nasdaq.comHere’s How ‘Smart Cities’ Focus On Resilience And Growth No Matter Who’s PresidentNovember 14, 2024 | forbes.comSMART High School Common App WorkshopOctober 26, 2024 | volunteermatch.orgV7 Smart Tips for Living a Joyful and Purpose-Driven LifeOctober 4, 2024 | fingerlakes1.comFLucky for Life prize worth $25K a year for life won for 3rd time in a weekSeptember 30, 2024 | mlive.comMMaximize Your Products' Lifespan with These Smart TricksSeptember 29, 2024 | msn.comSmart for Life Reports Significant Balance Sheet Improvement; Achieves Over $9.4 Million in Positive Net Stockholders' Equity Following Successful Restructuring EffortsSeptember 23, 2024 | globenewswire.comSmart for Life Provides Update Following Nasdaq Delisting Due to Audit Delays; Reports Plans to Reapply to Nasdaq Upon Full ComplianceSeptember 20, 2024 | globenewswire.comEufy’s Matter-enabled smart lock is 30% off todaySeptember 19, 2024 | msn.comSmart for Life Inc (SMFL) Stock Price Reaches $0.78: What Factors Are Influencing This Level?September 19, 2024 | bovnews.comBEufy’s new smart lock may Matter to Apple Home usersSeptember 18, 2024 | msn.comSmart supramolecular assembliesSeptember 18, 2024 | sciencedaily.comSLIFX A21 SuperColor Smart Light review: Affordable Hue alternativeSeptember 16, 2024 | yahoo.comEufy’s new smart lock is the company’s first with Matter supportSeptember 16, 2024 | msn.comSmart Homes for the Elderly: Making Life Easier and SaferSeptember 16, 2024 | msn.comSmart for Life Inc (SMFL) Stock: More Resilient Than It AppearsSeptember 13, 2024 | bovnews.comBInsider Buying: Smart for Life, Inc. (NASDAQ:SMFL) Major Shareholder Buys 17,722 Shares of StockSeptember 12, 2024 | insidertrades.comHRT Financial LP Acquires New Stake in Smart for Life IncSeptember 12, 2024 | finance.yahoo.comSmart For Life Announces Participation at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 9, 2024 | markets.businessinsider.comSmart for Life Inc (SMFL) Stock: Surpassing Expectations in the MarketSeptember 2, 2024 | bovnews.comBONCSQ, SMFL, AMPE, and PXMD Company DescriptionsAmpio Pharmaceuticals NYSE:AMPE$0.0027 0.00 (0.00%) As of 09/12/2025Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.OncoSec Medical NASDAQ:ONCSQOncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's product pipeline includes KEYNOTE-695, which is in Phase 2 trial for the treatment of advanced melanoma; TAVO + SARS-CoV-2 spike glycoprotein, which is in Phase 1 clinical trial for the treatment of COVID-19; and TAVO + epacadostat + pembrolizumab, which is in Phase 1 clinical trial for the treatment of squamous cell carcinoma head and neck cancer. Its pipeline also comprises TAVO +nivolumab, which is in Phase 2 clinical trial for the treatment of breast cancer; TAVO + CXCL9 for the treatment of solid tumors; and OMS-100 and OMS-102, which are in Phase 2 clinical trial for the treatment of metastatic melanoma. OncoSec Medical Incorporated has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890; and a research collaboration with Duke University's Center for Applied Therapeutics to evaluate TAVO in combination or sequenced with a HER2-plasmid vaccine. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated was incorporated in 2008 and is headquartered in Pennington, New Jersey. On June 14, 2023, OncoSec Medical Incorporated filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of New Jersey.PaxMedica NASDAQ:PXMD$0.0001 0.00 (-50.00%) As of 09/12/2025 02:17 PM EasternPaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. Its lead product candidate is PAX-101 that is in Phase 3 clinical trials, an intravenous formulation of suramin for the treatment of autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, fragile X syndrome, human African trypanosomiasis (HAT), and fragile X-associated tremor/ataxia syndrome. The company is developing PAX-102, an intranasal formulation of suramin for neurologic indications, as well as other new chemical entities that are targeted and selective antagonists of purine receptor subtypes; and PAX-HAT-301 for the treatment of HAT. It has a research collaboration agreement with PolarMar Health for Phase II clinical trial in austism spectrum disorder for emodin, which retains the rights for PolarMar to develop and commercialize any non-prescription supplement form of the product, and for PaxMedica, Inc. to retain exclusive rights to develop and commercialize a highly purified form of emodin. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York.Smart for Life NASDAQ:SMFL$0.0003 0.00 (-72.73%) As of 09/12/2025 10:32 AM EasternSmart for Life, Inc. acquires, develops, manufactures, operates, markets, and sells nutraceutical and related products in the United States and internationally. It offers natural health and wellness meal replacement products, including nutrition bars, cookies, soups and shakes, vitamins, and supplements under the Smart for Life brand; dietary supplements; and nutritional products, including whey protein isolate powder, tablet supplements for joint health, nitric oxide, post workout blends, Omega-3 supplements, and pre-workout supplements under the Sports Illustrated Nutrition brand for athletes and active lifestyle consumers. The company also provides various nutritional products, including antioxidant rich supplements, plant-based proteins, alkalizing nutrients, and weight management products. It sells its products through online market platforms. The company was formerly known as Bonne Santé Group, Inc. and changed its name to Smart for Life, Inc. in August 2021. Smart for Life, Inc. was founded in 2002 and is based in Boca Raton, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Football Season Is Here and DraftKings Stock Is Surging RH Stock Slides After Mixed Earnings and Tariff Concerns Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
